'In it for the long run': Tokalas merger building Oncternal's pipeline
By Jennifer Boggs
Managing Editor
Managing Editor
Friday, October 7, 2016
Earlier this year, the quiet joining of two recent San Diego-based startups led to the creation of Oncternal Therapeutics Inc., an oncology-focused firm boasting two potentially first-in-class drugs, both of which already have entered the clinic.
To continue reading subscribe now to Latest News
Learn More about Latest News
Already a subscriber? Sign In or Buy now to activate your subscription
Note: our contact information has changed
Customer Care: http://support.clarivate.com
© 2018 Clarivate Analytics.
Reproduction, reposting content is strictly prohibited.
Reproduction, reposting content is strictly prohibited.